JP2005512561A - 精子特異的カチオンチャネル、ｃａｔｓｐｅｒ２およびそれらの使用法 - Google Patents

精子特異的カチオンチャネル、ｃａｔｓｐｅｒ２およびそれらの使用法 Download PDF

Info

Publication number
JP2005512561A
JP2005512561A JP2003554846A JP2003554846A JP2005512561A JP 2005512561 A JP2005512561 A JP 2005512561A JP 2003554846 A JP2003554846 A JP 2003554846A JP 2003554846 A JP2003554846 A JP 2003554846A JP 2005512561 A JP2005512561 A JP 2005512561A
Authority
JP
Japan
Prior art keywords
catsper2
protein
seq
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003554846A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005512561A5 (enExample
Inventor
レン，ディジアン
クラファム，デイビッド，イー．
ガーバース，デイビッド，エル．
クイル，チモシー，エー．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Children's Hospital
Original Assignee
Boston Children's Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Children's Hospital filed Critical Boston Children's Hospital
Publication of JP2005512561A publication Critical patent/JP2005512561A/ja
Publication of JP2005512561A5 publication Critical patent/JP2005512561A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2003554846A 2001-10-22 2002-10-22 精子特異的カチオンチャネル、ｃａｔｓｐｅｒ２およびそれらの使用法 Pending JP2005512561A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34532401P 2001-10-22 2001-10-22
PCT/US2002/033676 WO2003054141A2 (en) 2001-10-22 2002-10-22 Sperm-specific cation channel, catsper2, and uses therefor

Publications (2)

Publication Number Publication Date
JP2005512561A true JP2005512561A (ja) 2005-05-12
JP2005512561A5 JP2005512561A5 (enExample) 2006-01-12

Family

ID=23354573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554846A Pending JP2005512561A (ja) 2001-10-22 2002-10-22 精子特異的カチオンチャネル、ｃａｔｓｐｅｒ２およびそれらの使用法

Country Status (7)

Country Link
US (1) US7339029B2 (enExample)
EP (1) EP1448589A4 (enExample)
JP (1) JP2005512561A (enExample)
AU (1) AU2002364939A1 (enExample)
CA (1) CA2462670A1 (enExample)
MX (1) MXPA04003750A (enExample)
WO (1) WO2003054141A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729248B2 (en) 2001-10-22 2014-05-20 Children's Medical Center Corporation Sperm-specific cation channel, CATSPER2, and uses therefor
US20050202539A1 (en) * 2004-03-11 2005-09-15 Hydra Biosciences System for screening eukaryotic membrane proteins
AU2005301152A1 (en) * 2004-10-29 2006-05-11 Genentech, Inc. Disruptions of genes encoding secreted proteins, compositions and methods relating thereto
AU2006259368A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof
WO2014070786A1 (en) 2012-10-29 2014-05-08 The University Of North Carolina At Chapel Hill Compositions and methods for inhibiting pathogen infection
CN113166236A (zh) 2018-09-21 2021-07-23 北卡罗来纳大学查佩尔希尔分校 限制穿过黏液的合成粘合剂
WO2020193446A1 (en) * 2019-03-22 2020-10-01 Westfälische Wilhelms-Universität Münster Catsper-activity-test for determining male infertility

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001054477A2 (en) 2000-01-25 2001-08-02 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1171460A4 (en) * 1999-04-09 2002-10-09 Human Genome Sciences Inc 48 HUMAN SECRETED PROTEINS
CA2378403A1 (en) 1999-07-26 2001-02-01 Genentech, Inc. Novel polynucleotides and method for the use thereof
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1430125A4 (en) * 2001-05-03 2005-01-19 Childrens Medical Center SPERM SPECIFIC CATION CHANNEL AND USES THEREOF
WO2003089583A2 (en) * 2002-04-16 2003-10-30 Origene Technologies, Inc. Tissue specific genes and gene clusters
AU2003235096A1 (en) 2002-04-24 2003-11-10 Takeda Chemical Industries, Ltd. Novel protein and dna thereof
GB0212067D0 (en) * 2002-05-24 2002-07-03 Impharmatica Ltd Proteins
WO2004023973A2 (en) * 2002-09-12 2004-03-25 Incyte Corporation Molecules for diagnostics and therapeutics

Also Published As

Publication number Publication date
EP1448589A2 (en) 2004-08-25
US7339029B2 (en) 2008-03-04
CA2462670A1 (en) 2003-07-03
WO2003054141A3 (en) 2004-03-11
AU2002364939A1 (en) 2003-07-09
MXPA04003750A (es) 2004-07-23
US20050142566A1 (en) 2005-06-30
EP1448589A4 (en) 2005-03-30
WO2003054141A2 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
US8852860B2 (en) Sperm-specific cation channel, CatSper1 and uses therefor
US20160353720A1 (en) Sperm-specific cation channel, catsper4, and uses therefor
US20160353721A1 (en) Sperm-Specific Cation Channel, Catsper3, and Uses Therefor
AU2002305322A1 (en) Sperm-specific cation channel, and uses therefor
US20170164591A1 (en) Sperm-Specific Cation Channel, Catsper2, and Uses Therefor
US7339029B2 (en) Sperm-specific cation channel, CatSper2, and uses therefor
JP2002506875A (ja) 第１８ｐ染色体関連障害の診断及び治療のための方法及び組成物
JP2002505104A (ja) レクトメディン物質および方法
US20030166155A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20050158312A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2001034173A1 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS
US20020076750A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
US20020028773A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
WO2002010366A2 (en) Methods and compositions for diagnosing and treating chromosome-18p related disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051019

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051019

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080812

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081111

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090113

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090209